Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Olmesartan Medoxomil

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

151 API Suppliers, 45 USDMF, 45 CEP/COS, 18 JDMF, 25 EU WC, 45 KDMF, 27 NDC API, 58 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

33 Drugs in Development

33 Drugs in Development

INTERMEDIATES

52 Intermediate Suppliers

52 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1494 FDF Dossiers, 222 FDA Orange Book, 884 Europe, 45 Canada, 162 Australia, 181 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 5MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 25MG;40MG, TABLET;ORAL - EQ 10MG BASE;20MG, TABLET;ORAL - EQ 10MG BASE;40MG, TABLET;ORAL - EQ 5MG BASE;20MG, TABLET;ORAL - EQ 5MG BASE;40MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 15 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 21 BASF, 3 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 9 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 32 Thickeners and Stabilizers, 30 Disintegrants & Superdisintegrants, 29 Direct Compression, 28 Granulation, 24 Controlled & Modified Release, 24 Lubricants & Glidants, 20 Topical, 16 Solubilizers, 15 Film Formers & Plasticizers, 12 Co-Processed Excipients, 10 Rheology Modifiers, 9 Parenteral, 9 Taste Masking, 8 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

96 News #PharmaBuzz

96 News #PharmaBuzz

GLOBAL SALES INFORMATION

35 US Medicaid Prescriptions, 223 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

31 APIs, 7 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 JP, 15 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Interquim SA	Spain	Interquim S. A.	227MF10298	Olmesartan Medoxomil	2015-12-28	2020-05-12	Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, Spain
29/11/2025	Active Pharma	Japan	Active Pharma Co., Ltd.	228MF10139	Olmesartan medoxomil	2016-08-02	2017-05-16	2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo

Olmesartan Medoxomil

Olmesartan Medoxomil

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

151 API Suppliers

45 USDMF

45 CEP/COS

18 JDMF

25 EU WC

45 KDMF

27 NDC API

58 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

33 Drugs in Development

INTERMEDIATES

52 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1494 FDF Dossiers

222 FDA Orange Book

884 Europe

45 Canada

162 Australia

181 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG

TABLET;ORAL - 40MG

TABLET;ORAL - 5MG

TABLET;ORAL - 12.5MG;20MG

TABLET;ORAL - 12.5MG;40MG

TABLET;ORAL - 25MG;40MG

TABLET;ORAL - EQ 10MG BASE;20MG

TABLET;ORAL - EQ 10MG BASE;40MG

TABLET;ORAL - EQ 5MG BASE;20MG

TABLET;ORAL - EQ 5MG BASE;40MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

4 SPI Pharma

15 DKSH

3 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

2 Kirsch Pharma

1 ACG Worldwide

3 Actylis

1 Aeon Procare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

21 BASF

3 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

1 Finar

7 Gangwal Chemicals

5 Ideal Cures

4 Ingredion Pharma Solutions

26 Kerry

4 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

21 Roquette

9 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals